Arbutus Biopharma Q3 EPS $0.30 Beats $(0.03) Estimate, Sales $299.000K Miss $1.388M Estimate
Benzinga Newsdesk 3 hours ago
NewsEarningsEarnings BeatsEarnings Misses
Arbutus Biopharma (NASDAQ:ABUS) reported quarterly earnings of $0.30 per share which beat the analyst consensus estimate of $(0.03) by 1100 percent. This is a 850 percent increase over losses of $(0.04) per share from
Arbutus Biopharma (NASDAQ:ABUS) reported quarterly earnings of $0.30 per share which beat the analyst consensus estimate of $(0.03) by 1100 percent. This is a 850 percent increase over losses of $(0.04) per share from the same period last year. The company reported quarterly sales of $299.000 thousand which missed the analyst consensus estimate of $1.388 million by 78.46 percent. This is a 43.48 percent decrease over sales of $529.000 thousand the same period last year.